Parkinsons Disease Therapeutics and Forecast - Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Parkinson's Disease Therapeutics
1.2 Key Market Segments
1.2.1 Parkinson's Disease Therapeutics Segment by Type
1.2.2 Parkinson's Disease Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Parkinson's Disease Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Parkinson's Disease Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Parkinson's Disease Therapeutics Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Parkinson's Disease Therapeutics Market Competitive Landscape
3.1 Global Parkinson's Disease Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Parkinson's Disease Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Parkinson's Disease Therapeutics Sales Sites, Area Served, Product Type
3.6 Parkinson's Disease Therapeutics Market Competitive Situation and Trends
3.6.1 Parkinson's Disease Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Parkinson's Disease Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Parkinson's Disease Therapeutics Industry Chain Analysis
4.1 Parkinson's Disease Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Parkinson's Disease Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Parkinson's Disease Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Parkinson's Disease Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Parkinson's Disease Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Parkinson's Disease Therapeutics Price by Type (2019-2024)
7 Parkinson's Disease Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Parkinson's Disease Therapeutics Market Sales by Application (2019-2024)
7.3 Global Parkinson's Disease Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Parkinson's Disease Therapeutics Sales Growth Rate by Application (2019-2024)
8 Parkinson's Disease Therapeutics Market Consumption by Region
8.1 Global Parkinson's Disease Therapeutics Sales by Region
8.1.1 Global Parkinson's Disease Therapeutics Sales by Region
8.1.2 Global Parkinson's Disease Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Parkinson's Disease Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Parkinson's Disease Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Parkinson's Disease Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Parkinson's Disease Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Parkinson's Disease Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Parkinson's Disease Therapeutics Market Production by Region
9.1 Global Production of Parkinson's Disease Therapeutics by Region (2019-2024)
9.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Region (2019-2024)
9.3 Global Parkinson's Disease Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Parkinson's Disease Therapeutics Production
9.4.1 North America Parkinson's Disease Therapeutics Production Growth Rate (2019-2024)
9.4.2 North America Parkinson's Disease Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Parkinson's Disease Therapeutics Production
9.5.1 Europe Parkinson's Disease Therapeutics Production Growth Rate (2019-2024)
9.5.2 Europe Parkinson's Disease Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Parkinson's Disease Therapeutics Production (2019-2024)
9.6.1 Japan Parkinson's Disease Therapeutics Production Growth Rate (2019-2024)
9.6.2 Japan Parkinson's Disease Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Parkinson's Disease Therapeutics Production (2019-2024)
9.7.1 China Parkinson's Disease Therapeutics Production Growth Rate (2019-2024)
9.7.2 China Parkinson's Disease Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
10 Key Companies Profile
10.1 Merck
10.1.1 Merck Parkinson's Disease Therapeutics Basic Information
10.1.2 Merck Parkinson's Disease Therapeutics Product Overview
10.1.3 Merck Parkinson's Disease Therapeutics Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck Parkinson's Disease Therapeutics SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Akorn
10.2.1 Akorn Parkinson's Disease Therapeutics Basic Information
10.2.2 Akorn Parkinson's Disease Therapeutics Product Overview
10.2.3 Akorn Parkinson's Disease Therapeutics Product Market Performance
10.2.4 Akorn Business Overview
10.2.5 Akorn Parkinson's Disease Therapeutics SWOT Analysis
10.2.6 Akorn Recent Developments
10.3 GSK
10.3.1 GSK Parkinson's Disease Therapeutics Basic Information
10.3.2 GSK Parkinson's Disease Therapeutics Product Overview
10.3.3 GSK Parkinson's Disease Therapeutics Product Market Performance
10.3.4 GSK Parkinson's Disease Therapeutics SWOT Analysis
10.3.5 GSK Business Overview
10.3.6 GSK Recent Developments
10.4 Novartis
10.4.1 Novartis Parkinson's Disease Therapeutics Basic Information
10.4.2 Novartis Parkinson's Disease Therapeutics Product Overview
10.4.3 Novartis Parkinson's Disease Therapeutics Product Market Performance
10.4.4 Novartis Business Overview
10.4.5 Novartis Recent Developments
10.5 Boehringer Ingelheim
10.5.1 Boehringer Ingelheim Parkinson's Disease Therapeutics Basic Information
10.5.2 Boehringer Ingelheim Parkinson's Disease Therapeutics Product Overview
10.5.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Product Market Performance
10.5.4 Boehringer Ingelheim Business Overview
10.5.5 Boehringer Ingelheim Recent Developments
10.6 Teva Pharmaceutical
10.6.1 Teva Pharmaceutical Parkinson's Disease Therapeutics Basic Information
10.6.2 Teva Pharmaceutical Parkinson's Disease Therapeutics Product Overview
10.6.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Product Market Performance
10.6.4 Teva Pharmaceutical Business Overview
10.6.5 Teva Pharmaceutical Recent Developments
10.7 Abbvie
10.7.1 Abbvie Parkinson's Disease Therapeutics Basic Information
10.7.2 Abbvie Parkinson's Disease Therapeutics Product Overview
10.7.3 Abbvie Parkinson's Disease Therapeutics Product Market Performance
10.7.4 Abbvie Business Overview
10.7.5 Abbvie Recent Developments
10.8 Kyowa Hakko Kirin Pharma
10.8.1 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Basic Information
10.8.2 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product Overview
10.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product Market Performance
10.8.4 Kyowa Hakko Kirin Pharma Business Overview
10.8.5 Kyowa Hakko Kirin Pharma Recent Developments
10.9 Astellas Pharma
10.9.1 Astellas Pharma Parkinson's Disease Therapeutics Basic Information
10.9.2 Astellas Pharma Parkinson's Disease Therapeutics Product Overview
10.9.3 Astellas Pharma Parkinson's Disease Therapeutics Product Market Performance
10.9.4 Astellas Pharma Business Overview
10.9.5 Astellas Pharma Recent Developments
10.10 Roche
10.10.1 Roche Parkinson's Disease Therapeutics Basic Information
10.10.2 Roche Parkinson's Disease Therapeutics Product Overview
10.10.3 Roche Parkinson's Disease Therapeutics Product Market Performance
10.10.4 Roche Business Overview
10.10.5 Roche Recent Developments
10.11 H.Lundbeck
10.11.1 H.Lundbeck Parkinson's Disease Therapeutics Basic Information
10.11.2 H.Lundbeck Parkinson's Disease Therapeutics Product Overview
10.11.3 H.Lundbeck Parkinson's Disease Therapeutics Product Market Performance
10.11.4 H.Lundbeck Business Overview
10.11.5 H.Lundbeck Recent Developments
10.12 Bausch Health
10.12.1 Bausch Health Parkinson's Disease Therapeutics Basic Information
10.12.2 Bausch Health Parkinson's Disease Therapeutics Product Overview
10.12.3 Bausch Health Parkinson's Disease Therapeutics Product Market Performance
10.12.4 Bausch Health Business Overview
10.12.5 Bausch Health Recent Developments
10.13 Apokyn
10.13.1 Apokyn Parkinson's Disease Therapeutics Basic Information
10.13.2 Apokyn Parkinson's Disease Therapeutics Product Overview
10.13.3 Apokyn Parkinson's Disease Therapeutics Product Market Performance
10.13.4 Apokyn Business Overview
10.13.5 Apokyn Recent Developments
10.14 Orion
10.14.1 Orion Parkinson's Disease Therapeutics Basic Information
10.14.2 Orion Parkinson's Disease Therapeutics Product Overview
10.14.3 Orion Parkinson's Disease Therapeutics Product Market Performance
10.14.4 Orion Business Overview
10.14.5 Orion Recent Developments
10.15 Stada Arzneimittel
10.15.1 Stada Arzneimittel Parkinson's Disease Therapeutics Basic Information
10.15.2 Stada Arzneimittel Parkinson's Disease Therapeutics Product Overview
10.15.3 Stada Arzneimittel Parkinson's Disease Therapeutics Product Market Performance
10.15.4 Stada Arzneimittel Business Overview
10.15.5 Stada Arzneimittel Recent Developments
10.16 US WorldMeds
10.16.1 US WorldMeds Parkinson's Disease Therapeutics Basic Information
10.16.2 US WorldMeds Parkinson's Disease Therapeutics Product Overview
10.16.3 US WorldMeds Parkinson's Disease Therapeutics Product Market Performance
10.16.4 US WorldMeds Business Overview
10.16.5 US WorldMeds Recent Developments
10.17 Desitin Arzneimittel
10.17.1 Desitin Arzneimittel Parkinson's Disease Therapeutics Basic Information
10.17.2 Desitin Arzneimittel Parkinson's Disease Therapeutics Product Overview
10.17.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Product Market Performance
10.17.4 Desitin Arzneimittel Business Overview
10.17.5 Desitin Arzneimittel Recent Developments
10.18 Endo Pharmaceuticals
10.18.1 Endo Pharmaceuticals Parkinson's Disease Therapeutics Basic Information
10.18.2 Endo Pharmaceuticals Parkinson's Disease Therapeutics Product Overview
10.18.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Product Market Performance
10.18.4 Endo Pharmaceuticals Business Overview
10.18.5 Endo Pharmaceuticals Recent Developments
11 Parkinson's Disease Therapeutics Market Forecast by Region
11.1 Global Parkinson's Disease Therapeutics Market Size Forecast
11.2 Global Parkinson's Disease Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Parkinson's Disease Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Parkinson's Disease Therapeutics Market Size Forecast by Region
11.2.4 South America Parkinson's Disease Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Parkinson's Disease Therapeutics by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Parkinson's Disease Therapeutics Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Parkinson's Disease Therapeutics by Type (2025-2032)
12.1.2 Global Parkinson's Disease Therapeutics Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Parkinson's Disease Therapeutics by Type (2025-2032)
12.2 Global Parkinson's Disease Therapeutics Market Forecast by Application (2025-2032)
12.2.1 Global Parkinson's Disease Therapeutics Sales (K Units) Forecast by Application
12.2.2 Global Parkinson's Disease Therapeutics Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Parkinson's Disease Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Parkinson's Disease Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Parkinson's Disease Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Parkinson's Disease Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Parkinson's Disease Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Therapeutics as of 2022)
Table 10. Global Market Parkinson's Disease Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Parkinson's Disease Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Parkinson's Disease Therapeutics Product Type
Table 13. Global Parkinson's Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Parkinson's Disease Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Parkinson's Disease Therapeutics Market Challenges
Table 22. Global Parkinson's Disease Therapeutics Sales by Type (K Units)
Table 23. Global Parkinson's Disease Therapeutics Market Size by Type (M USD)
Table 24. Global Parkinson's Disease Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Parkinson's Disease Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Parkinson's Disease Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Parkinson's Disease Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Parkinson's Disease Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Parkinson's Disease Therapeutics Sales (K Units) by Application
Table 30. Global Parkinson's Disease Therapeutics Market Size by Application
Table 31. Global Parkinson's Disease Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Parkinson's Disease Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Parkinson's Disease Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Parkinson's Disease Therapeutics Market Share by Application (2019-2024)
Table 35. Global Parkinson's Disease Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Parkinson's Disease Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Parkinson's Disease Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Parkinson's Disease Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Parkinson's Disease Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Parkinson's Disease Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Parkinson's Disease Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Parkinson's Disease Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. Global Parkinson's Disease Therapeutics Production (K Units) by Region (2019-2024)
Table 44. Global Parkinson's Disease Therapeutics Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Parkinson's Disease Therapeutics Revenue Market Share by Region (2019-2024)
Table 46. Global Parkinson's Disease Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Parkinson's Disease Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Parkinson's Disease Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Parkinson's Disease Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Parkinson's Disease Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Merck Parkinson's Disease Therapeutics Basic Information
Table 52. Merck Parkinson's Disease Therapeutics Product Overview
Table 53. Merck Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Merck Business Overview
Table 55. Merck Parkinson's Disease Therapeutics SWOT Analysis
Table 56. Merck Recent Developments
Table 57. Akorn Parkinson's Disease Therapeutics Basic Information
Table 58. Akorn Parkinson's Disease Therapeutics Product Overview
Table 59. Akorn Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Akorn Business Overview
Table 61. Akorn Parkinson's Disease Therapeutics SWOT Analysis
Table 62. Akorn Recent Developments
Table 63. GSK Parkinson's Disease Therapeutics Basic Information
Table 64. GSK Parkinson's Disease Therapeutics Product Overview
Table 65. GSK Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. GSK Parkinson's Disease Therapeutics SWOT Analysis
Table 67. GSK Business Overview
Table 68. GSK Recent Developments
Table 69. Novartis Parkinson's Disease Therapeutics Basic Information
Table 70. Novartis Parkinson's Disease Therapeutics Product Overview
Table 71. Novartis Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Novartis Business Overview
Table 73. Novartis Recent Developments
Table 74. Boehringer Ingelheim Parkinson's Disease Therapeutics Basic Information
Table 75. Boehringer Ingelheim Parkinson's Disease Therapeutics Product Overview
Table 76. Boehringer Ingelheim Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Boehringer Ingelheim Business Overview
Table 78. Boehringer Ingelheim Recent Developments
Table 79. Teva Pharmaceutical Parkinson's Disease Therapeutics Basic Information
Table 80. Teva Pharmaceutical Parkinson's Disease Therapeutics Product Overview
Table 81. Teva Pharmaceutical Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Teva Pharmaceutical Business Overview
Table 83. Teva Pharmaceutical Recent Developments
Table 84. Abbvie Parkinson's Disease Therapeutics Basic Information
Table 85. Abbvie Parkinson's Disease Therapeutics Product Overview
Table 86. Abbvie Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Abbvie Business Overview
Table 88. Abbvie Recent Developments
Table 89. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Basic Information
Table 90. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product Overview
Table 91. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Kyowa Hakko Kirin Pharma Business Overview
Table 93. Kyowa Hakko Kirin Pharma Recent Developments
Table 94. Astellas Pharma Parkinson's Disease Therapeutics Basic Information
Table 95. Astellas Pharma Parkinson's Disease Therapeutics Product Overview
Table 96. Astellas Pharma Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Astellas Pharma Business Overview
Table 98. Astellas Pharma Recent Developments
Table 99. Roche Parkinson's Disease Therapeutics Basic Information
Table 100. Roche Parkinson's Disease Therapeutics Product Overview
Table 101. Roche Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Roche Business Overview
Table 103. Roche Recent Developments
Table 104. H.Lundbeck Parkinson's Disease Therapeutics Basic Information
Table 105. H.Lundbeck Parkinson's Disease Therapeutics Product Overview
Table 106. H.Lundbeck Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. H.Lundbeck Business Overview
Table 108. H.Lundbeck Recent Developments
Table 109. Bausch Health Parkinson's Disease Therapeutics Basic Information
Table 110. Bausch Health Parkinson's Disease Therapeutics Product Overview
Table 111. Bausch Health Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Bausch Health Business Overview
Table 113. Bausch Health Recent Developments
Table 114. Apokyn Parkinson's Disease Therapeutics Basic Information
Table 115. Apokyn Parkinson's Disease Therapeutics Product Overview
Table 116. Apokyn Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Apokyn Business Overview
Table 118. Apokyn Recent Developments
Table 119. Orion Parkinson's Disease Therapeutics Basic Information
Table 120. Orion Parkinson's Disease Therapeutics Product Overview
Table 121. Orion Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Orion Business Overview
Table 123. Orion Recent Developments
Table 124. Stada Arzneimittel Parkinson's Disease Therapeutics Basic Information
Table 125. Stada Arzneimittel Parkinson's Disease Therapeutics Product Overview
Table 126. Stada Arzneimittel Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. Stada Arzneimittel Business Overview
Table 128. Stada Arzneimittel Recent Developments
Table 129. US WorldMeds Parkinson's Disease Therapeutics Basic Information
Table 130. US WorldMeds Parkinson's Disease Therapeutics Product Overview
Table 131. US WorldMeds Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 132. US WorldMeds Business Overview
Table 133. US WorldMeds Recent Developments
Table 134. Desitin Arzneimittel Parkinson's Disease Therapeutics Basic Information
Table 135. Desitin Arzneimittel Parkinson's Disease Therapeutics Product Overview
Table 136. Desitin Arzneimittel Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 137. Desitin Arzneimittel Business Overview
Table 138. Desitin Arzneimittel Recent Developments
Table 139. Endo Pharmaceuticals Parkinson's Disease Therapeutics Basic Information
Table 140. Endo Pharmaceuticals Parkinson's Disease Therapeutics Product Overview
Table 141. Endo Pharmaceuticals Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 142. Endo Pharmaceuticals Business Overview
Table 143. Endo Pharmaceuticals Recent Developments
Table 144. Global Parkinson's Disease Therapeutics Sales Forecast by Region (2025-2032) & (K Units)
Table 145. Global Parkinson's Disease Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 146. North America Parkinson's Disease Therapeutics Sales Forecast by Country (2025-2032) & (K Units)
Table 147. North America Parkinson's Disease Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 148. Europe Parkinson's Disease Therapeutics Sales Forecast by Country (2025-2032) & (K Units)
Table 149. Europe Parkinson's Disease Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 150. Asia Pacific Parkinson's Disease Therapeutics Sales Forecast by Region (2025-2032) & (K Units)
Table 151. Asia Pacific Parkinson's Disease Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 152. South America Parkinson's Disease Therapeutics Sales Forecast by Country (2025-2032) & (K Units)
Table 153. South America Parkinson's Disease Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 154. Middle East and Africa Parkinson's Disease Therapeutics Consumption Forecast by Country (2025-2032) & (Units)
Table 155. Middle East and Africa Parkinson's Disease Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 156. Global Parkinson's Disease Therapeutics Sales Forecast by Type (2025-2032) & (K Units)
Table 157. Global Parkinson's Disease Therapeutics Market Size Forecast by Type (2025-2032) & (M USD)
Table 158. Global Parkinson's Disease Therapeutics Price Forecast by Type (2025-2032) & (USD/Unit)
Table 159. Global Parkinson's Disease Therapeutics Sales (K Units) Forecast by Application (2025-2032)
Table 160. Global Parkinson's Disease Therapeutics Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Parkinson's Disease Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Parkinson's Disease Therapeutics Market Size (M USD), 2019-2032
Figure 5. Global Parkinson's Disease Therapeutics Market Size (M USD) (2019-2032)
Figure 6. Global Parkinson's Disease Therapeutics Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Parkinson's Disease Therapeutics Market Size by Country (M USD)
Figure 11. Parkinson's Disease Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Parkinson's Disease Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Parkinson's Disease Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Parkinson's Disease Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Parkinson's Disease Therapeutics Market Share by Type
Figure 18. Sales Market Share of Parkinson's Disease Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Parkinson's Disease Therapeutics by Type in 2023
Figure 20. Market Size Share of Parkinson's Disease Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Parkinson's Disease Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Parkinson's Disease Therapeutics Market Share by Application
Figure 24. Global Parkinson's Disease Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Parkinson's Disease Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Parkinson's Disease Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Parkinson's Disease Therapeutics Market Share by Application in 2023
Figure 28. Global Parkinson's Disease Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Parkinson's Disease Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Parkinson's Disease Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Parkinson's Disease Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Parkinson's Disease Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Parkinson's Disease Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Parkinson's Disease Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Parkinson's Disease Therapeutics Sales Market Share by Region in 2023
Figure 44. China Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Parkinson's Disease Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Parkinson's Disease Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Parkinson's Disease Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Parkinson's Disease Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Parkinson's Disease Therapeutics Production Market Share by Region (2019-2024)
Figure 62. North America Parkinson's Disease Therapeutics Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Parkinson's Disease Therapeutics Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Parkinson's Disease Therapeutics Production (K Units) Growth Rate (2019-2024)
Figure 65. China Parkinson's Disease Therapeutics Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Parkinson's Disease Therapeutics Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Parkinson's Disease Therapeutics Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Parkinson's Disease Therapeutics Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Parkinson's Disease Therapeutics Market Share Forecast by Type (2025-2032)
Figure 70. Global Parkinson's Disease Therapeutics Sales Forecast by Application (2025-2032)
Figure 71. Global Parkinson's Disease Therapeutics Market Share Forecast by Application (2025-2032)
